Erratum: Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation (British Journal of Pharmacology (2004) 142 (161-171) doi: 10.1038/sj.bjp.0705729);Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation

British Journal of Pharmacology

Volumn 142, Issue 1, 2004, Pages 161-171

  Ling, Ping ^a   Ngo, Karen ^a   Nguyen, Steven ^a   Thurmond, Robin L ^a   Edwards, James P ^a   Karlsson, Lars ^a   Fung Leung, Wai Ping ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adhesion molecules; Cell shape change; Chemotaxis; Eosinophils; Histamine

Indexed keywords

1 [(5 CHLORO 1H INDOL 2 YL)CARBONYL] 4 METHYLPIPERAZINE; ANTIHISTAMINIC AGENT; CELL ADHESION MOLECULE; CLOBENPROPIT; HISTAMINE; HISTAMINE H4 RECEPTOR; IMETIT; JNJ 7777120; THIOPERAMIDE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN;

ARTICLE; CELL SHAPE; CHEMOTAXIS; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; UPREGULATION; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

CELL ADHESION MOLECULES; CELL LINE; CELL SHAPE; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; UP-REGULATION;

EID: 2542530713     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705899     Document Type: Erratum

References (23)

1. BOUSQUET, J., CHANEZ, P., LACOSTE, J.Y., BARNEON, G., GHAVANIAN, N., ENANDER, I., VENGE, P., AHLSTEDT, S., SIMONY-LAFONTAINE, J., GODARD, P. & MICHEL, F.-B. (1990). Eosinophilic inflammation in asthma. N. Engl. J. Med., 323, 1033-1039.
2. CHURCH, M.K. & CAULFIELD, J.P. (1993). Mast cell and basophil function. In: Allergy, ed. Holgate, S.T. & Church, M.K. Chapter 5.6. New York: Raven Press Ltd.
3. CLARK, R.A., GALLIN, J.I. & KAPLAN, A.P. (1975). The selective eosinophil chemotactic activity of histamine. J. Exp. Med., 142, 1462-1476.
4. 4 receptor antagonists - the new antihistamines? Curr Opin Investing Drugs, in press.
5. HILL, S.J., GANELLIN, C.R., TIMMERMAN, H., SCHWARTZ, J.C., SHANKLEY, N.P., YOUNG, J.M., SCHUNACK, W., LEVI, R. & HAAS, H.L. (1997). International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev., 49, 253-278.
6. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther., 305, 1212-1221.
7. 4 receptor antagonists. J. Med. Chem., 46, 3957-3960.
8. 4 receptor ligands and their potential therapeutic uses. Mini Rev Med Chem., in press.
9. 2 receptors. Nature, 413, 420-425.
10. (4)) expressed in bone marrow. Mol. Pharmacol., 59, 420-426.
11. 4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther., 299, 121-130.
12. LUKACS, N.W. (2001). Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol., 1, 108-116.
13. MACFARLANE, A.J., KON, O.M., SMITH, S.J., ZEIBECOGLOU, K., KHAN, L.N., BARATA, L.T., MCEUEN, A.R., BUCKLEY, M.G., WALLS, A.F., MENG, Q., HUMBERT, M., BARNES, N.C., ROBINSON, D.S., YING, S. & KAY, A.B. (2000). Basophils, eosinophils and mast cells in atopic and nonatopic ashtma and in late-phase allergic reactions in the lung and skin. J. Allergy Clin. Immunol., 105, 99-107.
14. MORSE, K.L., BEHAN, J., LAZ, T.M., WEST JR., R.E., GREENFEDER, S.A., ANTHES, J.C., UMLAND, S., WAN, Y., HIPKIN, R.W., GONSIOREK, W., SHIN, N., GUSTAFSON, E.L., QIAO, X., WANG, S., HEDRICK, J.A., GREENE, J., BAYNE, M. & MONSMA JR., F.J. (2001). Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther., 296, 1058-1066.
15. NGUYEN, T., SHAPIRO, D.A., GEORGE, S.R., SETOLA, V., LEE, D.K., CHENG, R., RAUSER, L., LEE, S.P., LYNCH, K.R., ROTH, B.L. & O'DOWD, B.F. (2001). Discovery of a novel member of the histamine receptor family. Mol. Pharmacol., 59, 427-433.
16. ODA, T., MORIKA, W.A.N., SAITO, Y., MASUHO, Y. & MATSUMOTO, S. (2000). Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem., 275, 36781-36786.
17. 4 receptor on human eosinophils - role in eosinophil chemotaxis. J. Recept. Signal Transduct. Res., 22, 431-448.
18. SABROE, I., HARTNELL, A., JOPLING, L.A., BEL, S., PONATH, P.D., PEASE, J.E., COLLINS, P.D. & WILLIAMS, T.J. (1999). Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol., 162, 2946-2955.
19. 3 receptor antagonists. Bioorg. Med. Chem., 12, 3309-3312.
20. SPRINGER, T.A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
21. TACHIMOTO, H., EBISAWA, M. & BOCHNER, B.S. (2002). Crosstalk between integrins and chemokines that influences eosinophil adhesion and migration. Int. Arch. Allergy Immunol., 128, 18-20.
22. ZHU, Y., MICHALOVICH, D., WU, H., TAN, K.B., DYTKO, G.M., MANNAN, I.J., BOYCE, R., ALSTON, J., TIERNEY, L.A., LI, X., HERRITY, N.C., VAWTER, L., SARAU, H.M., AMES, R.S., DAVENPORT, C.M., HIEBLE, J.P., WILSON, S., BERGSMA, D.J. & FITZGERALD, L.R. (2001). Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol., 59, 434-441.
23. ZIMMERMANN, N. & ROTHENBERG, M.E. (2003). Receptor internalization is required for eotaxin-induced responses in human eosinophils. J. Allergy Clin. Immunol., 111, 97-105.